1. Home
  2. Bills
  3. H.R. 8454

H.R. 8454 · 117th Congress · 2021–2022

Medical Marijuana and Cannabidiol Research Expansion Act

H.R. 8454 in the 117th Congress (2021–2022) became law — introduced on Jul 21, 2022, sponsored by Earl Blumenauer with 10 co-sponsors. Congress held 1 roll call vote on it.

During the 117th Congress (2021–2022), Joe Biden was president, and Democrats held the House majority and Republicans the Senate majority.

Status
Became law
Introduced
Jul 21, 2022
Co-sponsors
10
Policy area
Crime and Law Enforcement
Public law
Public Law 117-215

What it does

Medical Marijuana and Cannabidiol Research Expansion Act This act establishes a new, separate registration process to facilitate research on marijuana. Specifically, the act directs the Drug Enforcement Administration (DEA) to follow procedures specified in the act to register (1) practitioners to conduct marijuana research, and (2) manufacturers to supply marijuana for the research.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Earl Blumenauer (D-OR). Co-sponsors: 6 Democrats, 4 Republicans.

Where it stands

  • IntroducedJul 21, 2022
  • Passed the HouseJul 26, 2022
  • Passed the SenateNov 16, 2022
  • Sent to the PresidentNov 29, 2022
  • Became lawDec 2, 2022

Latest action: Became Public Law No: 117-215. (Dec 2, 2022)

How Congress voted

  • On Motion to Suspend the Rules and Pass, as Amended
    House · Jul 26, 2022 · Passed
    325–95

Every roll call vote on this bill

More bills from Earl Blumenauer in the 117th Congress

Other Crime and Law Enforcement bills in the 117th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 8454 (117th Congress): Medical Marijuana and Cannabidiol…,” https://www.capitolreceipts.com/bill/117-hr-8454/medical-marijuana-and-cannabidiol-research-expansion-act (accessed 2026-10-17).

Open the interactive version ›